ORGO
Price
$4.29
Change
+$0.06 (+1.42%)
Updated
Oct 3 closing price
Capitalization
544.22M
32 days until earnings call
PRGO
Price
$22.51
Change
+$0.36 (+1.63%)
Updated
Oct 3 closing price
Capitalization
3.1B
31 days until earnings call
Interact to see
Advertisement

ORGO vs PRGO

Header iconORGO vs PRGO Comparison
Open Charts ORGO vs PRGOBanner chart's image
Organogenesis Holdings
Price$4.29
Change+$0.06 (+1.42%)
Volume$985.56K
Capitalization544.22M
Perrigo
Price$22.51
Change+$0.36 (+1.63%)
Volume$1.6M
Capitalization3.1B
ORGO vs PRGO Comparison Chart in %
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORGO vs. PRGO commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORGO is a Hold and PRGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 05, 2025
Stock price -- (ORGO: $4.29 vs. PRGO: $22.51)
Brand notoriety: ORGO and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ORGO: 121% vs. PRGO: 83%
Market capitalization -- ORGO: $544.22M vs. PRGO: $3.1B
ORGO [@Pharmaceuticals: Generic] is valued at $544.22M. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $3.1B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.89B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORGO’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 2 green FA rating(s).

  • ORGO’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 2 green, 3 red.
According to our system of comparison, PRGO is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORGO’s TA Score shows that 4 TA indicator(s) are bullish while PRGO’s TA Score has 5 bullish TA indicator(s).

  • ORGO’s TA Score: 4 bullish, 6 bearish.
  • PRGO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than ORGO.

Price Growth

ORGO (@Pharmaceuticals: Generic) experienced а +4.63% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +4.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.81%. For the same industry, the average monthly price growth was +6.75%, and the average quarterly price growth was +54.33%.

Reported Earning Dates

ORGO is expected to report earnings on Nov 06, 2025.

PRGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.81% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($3.1B) has a higher market cap than ORGO($544M). PRGO has higher P/E ratio than ORGO: PRGO (2818.00) vs ORGO (63.75). ORGO YTD gains are higher at: 34.062 vs. PRGO (-9.492). PRGO has higher annual earnings (EBITDA): 612M vs. ORGO (3.19M). PRGO has more cash in the bank: 454M vs. ORGO (73.1M). ORGO has less debt than PRGO: ORGO (40.8M) vs PRGO (3.65B). PRGO has higher revenues than ORGO: PRGO (4.33B) vs ORGO (429M).
ORGOPRGOORGO / PRGO
Capitalization544M3.1B18%
EBITDA3.19M612M1%
Gain YTD34.062-9.492-359%
P/E Ratio63.752818.002%
Revenue429M4.33B10%
Total Cash73.1M454M16%
Total Debt40.8M3.65B1%
FUNDAMENTALS RATINGS
ORGO vs PRGO: Fundamental Ratings
ORGO
PRGO
OUTLOOK RATING
1..100
817
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
5580
P/E GROWTH RATING
1..100
102
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for ORGO (74) in the Financial Conglomerates industry. This means that PRGO’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's Profit vs Risk Rating (98) in the Financial Conglomerates industry is in the same range as PRGO (100) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as ORGO (94) in the Financial Conglomerates industry. This means that PRGO’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's Price Growth Rating (55) in the Financial Conglomerates industry is in the same range as PRGO (80) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as ORGO (10) in the Financial Conglomerates industry. This means that PRGO’s stock grew similarly to ORGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORGOPRGO
RSI
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 3 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
59%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
66%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 5 days ago
61%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 14 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
70%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDMAX141.771.04
+0.74%
Janus Henderson Enterprise A
PGIIX28.250.12
+0.43%
Polen Global Growth Institutional
DMAGX19.130.07
+0.37%
Driehaus Global Fund
PAXLX14.450.04
+0.28%
Impax Large Cap Fund Individual Investor
GAOCX21.770.05
+0.23%
JPMorgan Global Allocation C